Ms. Barrett is a highly regarded industry leader with extensive experience leading business organizations and Fortune 500 pharmaceutical companies. Ms. Barrett has served as director and our President and Chief Executive Officer since January 2019. Prior to UroGen, Ms. Barrett was CEO of Novartis Oncology and a member of the Novartis Executive Committee since February 2018. Prior to Novartis, Ms. Barrett served at Pfizer, Inc. in various leadership capacities, most recently as the Global President of Oncology and, before that, as President of Global Innovative Pharma for Europe, President of the Specialty Care Business Unit for North America, and Regional President of United States Oncology. Before Pfizer, Ms. Barrett held positions at Cephalon, Inc., where she was Vice President and General Manager of the Oncology Business Unit, and at Johnson & Johnson. She started her career at Kraft Foods Group Inc. Ms. Barrett also currently serves on the boards of directors of Sage Therapeutics and Allogene Therapeutics. Ms. Barrett received an M.B.A. degree in marketing from Saint Joseph's University and a B.S. from the University of Louisiana.